CHARACTERIZATION OF THE INHIBITION OF U46619-MEDIATED HUMAN-PLATELET ACTIVATION BY THE TRIMETOQUINOL ISOMERS - EVIDENCE FOR ENDOPEROXIDE THROMBOXANE-A2 RECEPTOR BLOCKADE

被引：0
作者：
AHN, CH
ROMSTEDT, KJ
WALLACE, LJ
MILLER, DD
FELLER, DR
机构：
[1] OHIO STATE UNIV,COLL PHARM,DIV PHARMACOL,COLUMBUS,OH 43210
[2] OHIO STATE UNIV,COLL PHARM,DIV MED CHEM,COLUMBUS,OH 43210
来源：
BIOCHEMICAL PHARMACOLOGY | 1988年 / 37卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：3023 / 3033
页数：11
相关论文
共 38 条
[21]   EFFECTS OF MAGNESIUM AND ISRADIPINE ON CONTRACTILE ACTIVATION INDUCED BY THE THROMBOXANE-A2 ANALOG U46619 IN HUMAN UTEROPLACENTAL ARTERIES IN TERM PREGNANCY [J].
SKAJAA, K ;
SVANE, D ;
ANDERSSON, KE ;
FORMAN, A .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (04) :1323-1333
[22]   EFFECT OF THROMBOXANE-A2 SYNTHETASE INHIBITION, SINGLY AND COMBINED WITH THROMBOXANE-A2 PROSTAGLANDIN ENDOPEROXIDE RECEPTOR ANTAGONISM, ON INOSITOL PHOSPHOLIPID TURNOVER AND ON 5-HT RELEASE BY WASHED HUMAN PLATELETS [J].
DECOURCELLES, DD ;
DECLERCK, F .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1990, 188 (2-3) :161-169
[23]   ADENOSINE POTENTIATES THE INHIBITORY EFFECTS OF CALCIUM-CHANNEL ANTAGONISTS ON HUMAN PLATELET-AGGREGATION INDUCED BY THROMBOXANE-A2 OR U46619 [J].
JOHNSON, GJ ;
LEIS, LA ;
FRANCIS, GS .
THROMBOSIS RESEARCH, 1990, 59 (01) :139-148
[24]   INHIBITION OF HUMAN-PLATELET AGGREGATION AND THROMBOXANE-B2 PRODUCTION BY MELATONIN - EVIDENCE FOR A DIURNAL-VARIATION [J].
DELZAR, MD ;
MARTINUZZO, M ;
FALCON, C ;
CARDINALI, DP ;
CARRERAS, LO ;
VACAS, MI .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1990, 70 (01) :246-251
[25]   IRREVERSIBLE BLOCKADE OF THE U 46619-INDUCED PLATELET ACTIVATION BY A PHOTOLABILE TXA2/PGH2 RECEPTOR ANTAGONIST [J].
ZEHENDER, H ;
WITTE, EC ;
WOLFF, HP ;
STEGMEIER, K ;
PATSCHEKE, H .
JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1986, 24 (10) :780-781
[26]   THE DIHYDROPYRIDINE CALCIUM-CHANNEL AGONIST, BAY K 8644, AND THE ANTAGONIST, NIFEDIPINE, INHIBIT U46619-INDUCED HUMAN-PLATELET ACTIVATION BY COMPETITIVE-BINDING TO THE THROMBOXANE A2/PGH2 RECEPTOR [J].
JOHNSON, GJ ;
DUNLOP, PC ;
LEIS, LA ;
FROM, AHL .
THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) :262-262
[27]   EVIDENCE FOR INHIBITION BY ENDOTHELIUM-DERIVED RELAXING FACTOR OF THROMBOXANE-A2 RECEPTOR-MEDIATED VASOCONSTRICTION IN THE FETAL VESSELS OF THE HUMAN PERFUSED PLACENTA [J].
GUDE, NM ;
BOURA, ALA ;
KING, RG ;
BRENNECKE, SP ;
JAMAL, OS ;
SMITH, R ;
WALTERS, WAW .
PLACENTA, 1992, 13 (06) :597-605
[28]   DIFFERENTIAL-EFFECTS OF THROMBOXANE-A2 SYNTHETASE INHIBITION SINGLY OR COMBINED WITH PROSTAGLANDIN ENDOPEROXIDE RECEPTOR BLOCKADE (R-68070) ON PHOSPHATIDYLINOSITIDE TURNOVER AND ON SEROTONIN RELEASE BY WASHED HUMAN-PLATELETS [J].
DECOURCELLES, DD ;
DECLERCK, F .
THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) :102-102
[29]   PHOTOAFFINITY-LABELING AND ISOELECTRIC-FOCUSING OF THE HUMAN-PLATELET THROMBOXANE-A2 PROSTAGLANDIN-H2 (TXA2/PGH2) RECEPTOR [J].
MAIS, DE ;
HALUSHKA, PV .
ADVANCES IN PROSTAGLANDIN THROMBOXANE AND LEUKOTRIENE RESEARCH, 1989, 19 :168-171
[30]   ANTIPEPTIDE ANTIBODIES AGAINST THE HUMAN BLOOD-PLATELET THROMBOXANE-A2/PROSTAGLANDIN-H2 RECEPTOR - PRODUCTION, PURIFICATION AND CHARACTERIZATION [J].
BORG, C ;
LAM, SCT ;
DIETER, JP ;
LIM, CT ;
KOMIOTIS, D ;
VENTON, DL ;
LEBRETON, GC .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (10) :2071-2078
1234